期刊文献+

NP方案时辰化疗治疗晚期乳腺癌临床观察 被引量:3

NP time-chemotherapy regimen for advanced breast cancer
全文增补中
导出
摘要 目的比较NP方案时辰化疗与常规化疗治疗晚期乳腺癌的疗效及毒副作用。方法将52例晚期乳腺癌患者随机分为2组,2组均采用NP方案。时辰化疗组长春瑞滨(NVB)25mg/m^2静脉注射,17:00,第1、8天,顺铂(DDP)30 mg/m^2持续静脉滴注,10:00~16:00,第1~3天。而常规化疗组NVB与DDP均于10:00用药。结果时辰化疗组总有效率为69.2%;常规化疗组总有效率为30.8%,两组疗效比较差异有统计学意义(P<0.01)。主要毒副反应为血液学毒性及胃肠道反应,时辰化疗组均低于常规化疗组。结论NP方案时辰化疗疗效优于常规化疗,且毒副作用小。 Objective To compare the response and adverse reactions of NP time-chemotherapy with that of routine NP for advanced breast cancer.Methods 52 patients with advanced breast cancer were ran- domly assigned to groupA which received NP time-chemotherapy,or group B which received routine NP.Re- suits The overall response rate is 69.2 % in Group A compare to 30.8 % in group B,there was significant difference(P<0.01).The main adverse reactions include marrow suppression and gastrointestinal reactions, which is lower in Group A than in group B.Conclusion Compared to routine NP,NP Time-chemotherapy is an active and safe regimen for advanced breast cancer.
出处 《肿瘤研究与临床》 CAS 2007年第4期252-253,共2页 Cancer Research and Clinic
关键词 乳腺肿瘤 抗肿瘤联合化疗方案 时辰化疗 Breast neoplasms Antineoplastic combined chemotherapy protocols Timechemotherapy
  • 相关文献

参考文献5

  • 1郭灵,林焕新,冼励坚.恶性肿瘤时辰化疗的基础理论及实践[J].中国肿瘤临床,2004,31(1):56-59. 被引量:33
  • 2Lévi F.Chronopharmacology of anticancer agents. Physiology and Pharmacology of Biological Rhythm . 1997
  • 3Filipski E,Amat S,Lemaigre G,et al.Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice. Journal of Pharmacology and Experimental Therapeutics . 1999
  • 4Boughattas NA,Levi F,Fournier C,et al.Stable Circadian Mechanisms of Toxicity of Two Platinum Analogs (Cisplatin and Carboplatin) Despite Repeated Dosages in Mice. J. Pharmacol. Exp. Ther . 1990
  • 5Levi F,Metzger G,Massari C,et al.Oxaliplatin: pharmacokinetics and chronopharmacological aspects. Clinical Pharmacology . 2000

二级参考文献24

  • 1[1]Dunlap J C. Molecular Base for Circadian Clock[J]. Cell,1999,96(2): 271~290
  • 2[2]Hrushesky WJM, Bjarnaso GA. Circadian Cancer Therapy[J].J Clin Oncol, 1993, 11(7): 1403~1417
  • 3[3]Lévi F. Circadian Chronotherapy for Human Cancers [J].Lancet Oncol, 2001, 2(5): 307~315
  • 4[4]Lévi F. Chronopharmacology of anticancer agents. In: Redfern PH, Lemmer B, eds. Physiology and pharmacology of biological rhythm[M]. Berlin: Springer-Verlag. 1997, 299~311
  • 5[5]Granda TG, Lévi F. Tumor Based Rhythms of Anticancer Efficacy in Experimenral Models[J]. Chronobiol Int, 2002, 19(1):21~41
  • 6[6]Granda TG, Filipski E, D'Attino RM, et al. Experimental Chronotherapy of Mouse Mammary Adenocarcinoma MA13/C with docetaxel and Doxorubicine as Single Agent and in Combination[J]. Cancer Res, 2001, 61(5): 1996~2001
  • 7[7]Smaaland R, Sothern R B, Laerum O D, et al. Rhythm in Human Bone Marrow and Blood Cells [J]. Chronobiol Int,2002, 19(1): 101~127
  • 8[8]Bjarnason GA, Jodan R. Rhythm in Human gastrointestinal Mucosa and Skin[J]. Chronobiol Int, 2002, 19(1): 129~140
  • 9[9]Harris BE, Song R, Soong SJ, et al. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil level: evidence for circadian variation of plasma drug level in cancer patients receiving 5-fluorouracil by protracted continuous infusion[J]. Cancer Res, 1990, 50(1): 197~201
  • 10[10]Petit E, Milano G, Lévi F, et al. Circadian Varying Plasma Concentration of 5-Fluorouracil During 5-Day Continuous Venous Infusion at Constant Rate in Cancer Patients[J]. Cancer Res, 1988, 48(6): 1676~1679

共引文献32

同被引文献117

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部